Our Locations & Activities in Asia Pacific

STADA Pharmaceuticals (Asia) Ltd is the Asia Pacific (APAC) Regional Headquarters for STADA Arzneimittel AG, one of the leading Pharma companies in Europe. STADA Asia is a dedicated healthcare service provider to the APAC region, with subsidiaries in selected key markets such as Australia, China, Philippines, and Thailand, as well as a network of trusted, independent partner companies. STADA Asia is also a key player in consumer healthcare market in Hong Kong.

STADA Australia is a speciality pharmaceutical company with a product focus on infusion therapies in Neurology and Pain Management.

We work closely with Britannia Pharmaceuticals in the UK, a wholly owned subsidiary of STADA, to ensure the latest innovative therapies and advancements in Europe are brought to Australia and New Zealand for Parkinson's disease. In August 2016, STADA Australia commercialise three ready-to-use infusion pharmaceuticals in Australia and New Zealand for post-operative pain management.

In May 2005 Stada Beijing was established through the acquisition of Beijing Center-Lab Pharmaceutical Company Ltd. (BCP). STADA Beijing is located in the Economical Development Zone of Miyun, Beijing, covering an area of 13,258 M2, with GMP standard manufacturing equipment and facilities. By upholding its fine tradition and adhering to the principles of “quality first and continuous innovation”, STADA Beijing has been committed to providing safe and effective products to the Chinese consumer.

Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. It had a long lasting history of selling pharmaceutical products in the Philippines, formerly through Croma Medic Inc., which was renamed to STADA Philippines. After the formal launch in 2018, the company is driven by a shared purpose ‘’Caring for people’s health as a trusted partner’’ by offering quality medicines to all Filipinos at reasonable prices across all segments of healthcare; specialty, generics and consumer health.